Pliant Therapeutics Inc’s filing revealed that its Chief Medical Officer Lefebvre Eric unloaded Company’s shares for reported $0.14 million on Jul 10 ’24. In the deal valued at $11.56 per share,12,319 shares were sold. As a result of this transaction, Lefebvre Eric now holds 213,052 shares worth roughly $2.39 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hull Hans sold 9,900 shares, generating $114,444 in total proceeds. Upon selling the shares at $11.56, the Chief Business Officer now owns 227,494 shares.
Before that, Cummings Keith Lamont sold 10,911 shares. Pliant Therapeutics Inc shares valued at $126,131 were divested by the Chief Financial Officer at a price of $11.56 per share. As a result of the transaction, Cummings Keith Lamont now holds 282,115 shares, worth roughly $3.17 million.
A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early December with a ‘”an Overweight”‘ rating. Canaccord Genuity began covering PLRX with “Buy” recommendation on May 18, 2023. Robert W. Baird started covering the stock on April 13, 2023. It rated PLRX as “an Outperform”.
Price Performance Review of PLRX
On Tuesday, Pliant Therapeutics Inc [NASDAQ:PLRX] saw its stock jump 1.08% to $11.24. Over the last five days, the stock has gained 6.54%. Pliant Therapeutics Inc shares have fallen nearly -37.93% since the year began. Nevertheless, the stocks have fallen -36.17% over the past one year. While a 52-week high of $19.62 was reached on 01/08/24, a 52-week low of $10.22 was recorded on 10/02/24. SMA at 50 days reached $12.47, while 200 days put it at $13.97.
Levels Of Support And Resistance For PLRX Stock
The 24-hour chart illustrates a support level at 11.08, which if violated will result in even more drops to 10.93. On the upside, there is a resistance level at 11.42. A further resistance level may holdings at 11.60. The Relative Strength Index (RSI) on the 14-day chart is 43.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.42%. Stochastics %K at 36.50% indicates the stock is a holding.
How much short interest is there in Pliant Therapeutics Inc?
A steep rise in short interest was recorded in Pliant Therapeutics Inc stocks on 2024-09-13, dropping by 39998.0 shares to a total of 7.3 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 7.34 million shares. There was a decline of -0.55%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 14, 2022 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $33 price target.
